News
AI training targets 50,000 doctors in India to strengthen medical skills
AI training targets 50,000 doctors in India to strengthen medical skills
Over 42,000 doctors have already registered.
India biopharma pipeline jumps to 450 assets from 270: McKinsey
McKinsey said India has more than 2,050 WHO GMP-certified sites.
Japan leads Asia with 24 FDA novel-drug approvals: McKinsey
Regulatory fast-track supports global approvals, McKinsey says
South Korea secures $4.2b biologics deals as advanced biopharma activity expands
Licensing, funding, and IPO activity support sector development
China commands 30% of global biopharma pipeline; drives Asia’s share to 43%
The country transitions from fast follower to global innovation frontrunner.
IHH Healthcare Singapore signs MoU with Medistra to boost liver care
Partnership covers clinical excellence and training.
Beijing palliative care training expands as Singapore steps in
Programme to train over 1,000 healthcare professionals
Limited imaging infrastructure drives MRI growth in India
The country accounted for 22% of the Asia–Pacific MRI market in 2025.
Australia pharma to reach $24.5b by 2030 despite 'anniversary' price cuts
Pharmaceutical spending is driven by demand and new product launches, says BMI.
Australia expands Medicare incentives to increase GP bulk billing
Changes could save families hundreds of dollars in medical costs.
Matched savings push grows as 750,000 qualify for MRSS in 2026: MOH
Top-ups made in 2026 get credited at the start of 2027, with notices from end-January 2026.
Greater China healthcare keeps 'overweight' rating as R&D, biotech drive expansion
Outlook still positive despite trade and regulatory risks.
AI and mobile vans fuel $4.2B OCT market surge
Asia-Pacific emerges as fastest-growing OCT market.
Mindray and IHH partnership accelerates digital, value-based hospital care
The partnership covers Gleneagles, Parkway, Acibadem, and Fortis hospitals.
NZ targets 500 extra surgeries; Hutt Hospital to hit 25 sessions monthly
Keneperu acquired new equipment to end regional surgery delays.
VPD outbreak risks loom as coverage falls below 85%: report
A vaccine-preventable disease outbreak may be caused by routine immunisation gaps, donor fatigue, and complex programmes.
Radiopharmaceuticals market tracks 8% CAGR as size nears $11.66b
The forecast shows steady expansion from $6.76b 2022 base.
Most Read
1. China healthcare firms offset policy pressure with global growth 2. Private hospital plan takes shape in Singapore amidst public hospital overload 3. Kai Tak Hospital to launch first phase of services in October 4. Lung cancer surgery market set for $2.8b expansion by 2036 on rising cases 5. How can the Philippines fix health funding imbalances?Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
More than 300 exhibitors and 170 startups will showcase solutions across medical fields.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight